Cambridge Investment Research Advisors
NVOS

Cambridge Investment Research Advisors’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio NVOS Stock Details NVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,450
Closed -$4K – 3343
2023
Q3 		$4K Buy
+1,450
New +$2.65K ﹤0.01% 3128

Other funds holding NVOS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cambridge Investment Research Advisors's NVOS Position: Q4 2023 in Review

Cambridge Investment Research Advisors sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q4 2023, closing a stake of 1,450 shares — an estimated $4K sold.

Cambridge Investment Research Advisors first reported a position in NVOS in Q3 2023 and held it in 1 quarter. The position peaked at $4K in Q3 2023. 16 funds tracked by Wall St. Rank hold NVOS as of Q4 2023.

  • Cambridge Investment Research Advisors reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 1,450 Novo Integrated Sciences, Inc. Common Stock shares in Q4 2023, an estimated $4K.
  • Cambridge Investment Research Advisors first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Novo Integrated Sciences, Inc. Common Stock position peaked at $4K in Q3 2023.
  • 16 funds tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q4 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.